This preclinical study investigated the anti-obesity effects of combining the beta-cell hormone amylin with either phentermine or sibutramine in diet-induced obese (DIO) rats. The researchers administered amylin, phentermine, sibutramine, and their combinations to DIO rats and monitored changes in body weight, food intake, and adiposity. The combination therapies resulted in
